Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals.
Lim WH, Lin SY, Ng CH, Tan DJH, Xiao J, Yong JN, Tay PWL, Syn N, Chin YH, Chan KE, Khoo CM, Chew N, Foo RSY, Shabbir A, Tan EX, Huang DQ, Noureddin M, Sanyal AJ, Siddiqui MS, Muthiah MD. Lim WH, et al. Among authors: sanyal aj. Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):658-670. doi: 10.21037/hbsn-21-520. Epub 2022 Jun 20. Hepatobiliary Surg Nutr. 2023. PMID: 37886204 Free PMC article.
Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu.
Patel S, Siddiqui MB, Chandrakumaran A, Rodriguez VA, Faridnia M, Hernandez Roman J, Zhang E, Patrone MV, Kakiyama G, Walker C, Sima A, Minniti RJ, Boyett S, Bajaj JS, Sanyal A, Pandak WM, Bhati C, Siddiqui MS. Patel S, et al. Dig Dis Sci. 2021 Jan;66(1):263-272. doi: 10.1007/s10620-020-06196-4. Epub 2020 Mar 18. Dig Dis Sci. 2021. PMID: 32189102
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, Loomba R, Chalasani N, Kowdley K, Hameed B, Wilson LA, Yates KP, Belt P, Lazo M, Kleiner DE, Behling C, Tonascia J; NASH Clinical Research Network (CRN). Sanyal AJ, et al. N Engl J Med. 2021 Oct 21;385(17):1559-1569. doi: 10.1056/NEJMoa2029349. N Engl J Med. 2021. PMID: 34670043 Free PMC article.
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
Tang A, Ng CH, Phang PH, Chan KE, Chin YH, Fu CE, Zeng RW, Xiao J, Tan DJH, Quek J, Lim WH, Mak LY, Wang JW, Chew NWS, Syn N, Huang DQ, Siddiqui MS, Sanyal A, Muthiah M, Noureddin M. Tang A, et al. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1750-1760.e12. doi: 10.1016/j.cgh.2022.06.029. Epub 2022 Jul 19. Clin Gastroenterol Hepatol. 2023. PMID: 35863685 Review.
Complete alcohol abstinence increases the risk of NAFLD but not severity. A population analysis with transient elastography.
Xiao J, Ng CH, Chan KE, Tang ASP, Teh R, Ling AHZ, Yong JN, Lim WH, Tan DJH, Tan C, Win KM, Bwa AH, Chew NWS, Huang D, Dan YY, Noureddin M, Siddiqui MS, Sanyal A, Tamaki N, Muthiah M. Xiao J, et al. Scand J Gastroenterol. 2023 Jan;58(1):76-82. doi: 10.1080/00365521.2022.2105168. Epub 2022 Aug 9. Scand J Gastroenterol. 2023. PMID: 35944527
Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals.
Ng CH, Teng ML, Chew NW, Chan KE, Yong JN, Quek J, Tan DJH, Lim WH, Lee GSJ, Wong J, Kaewdech A, Huang DQ, Wang J, Chan MY, Noureddin M, Siddiqui MS, Sanyal A, Muthiah M. Ng CH, et al. Expert Rev Gastroenterol Hepatol. 2022 Sep;16(9):895-901. doi: 10.1080/17474124.2022.2119128. Epub 2022 Sep 2. Expert Rev Gastroenterol Hepatol. 2022. PMID: 36036200
The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis.
Chin YH, Ng CH, Chew NW, Kong G, Lim WH, Tan DJH, Chan KE, Tang A, Huang DQ, Chan MY, Figtree G, Wang JW, Shabbir A, Khoo CM, Wong VW, Young DY, Siddiqui MS, Noureddin M, Sanyal A, Cummings DE, Syn N, Muthiah MD. Chin YH, et al. EClinicalMedicine. 2022 Sep 29;54:101685. doi: 10.1016/j.eclinm.2022.101685. eCollection 2022 Dec. EClinicalMedicine. 2022. PMID: 36193169 Free PMC article.
Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis.
Siddiqui MS, Parmar D, Sheikh F, Sarin SK, Cisneros L, Gawrieh S, Momin T, Duseja A, Sanyal AJ. Siddiqui MS, et al. Among authors: sanyal aj. Clin Gastroenterol Hepatol. 2023 Sep;21(10):2597-2605.e2. doi: 10.1016/j.cgh.2023.01.018. Epub 2023 Jan 31. Clin Gastroenterol Hepatol. 2023. PMID: 36731585
718 results